| Literature DB >> 33922658 |
Ji-Hee Nam1, Jun-Ho Lee2, So-Yeon Choi1, Nam-Chul Jung2, Jie-Young Song3, Han-Geuk Seo4, Dae-Seog Lim1.
Abstract
Dendritic cells (DCs) are the most potent professional antigen-presenting cells (APCs) and inducers of T cell-mediated immunity. Although DCs play a central role in promoting adaptive immune responses against growing tumors, they also establish and maintain peripheral tolerance. DC activity depends on the method of induction and/or the presence of immunosuppressive agents. Tolerogenic dendritic cells (tDCs) induce immune tolerance by activating CD4+CD25+Foxp3+ regulatory T (Treg) cells and/or by producing cytokines that inhibit T cell activation. These findings suggest that tDCs may be an effective treatment for autoimmune diseases, inflammatory diseases, and infertility.Entities:
Keywords: autoimmune disease; dendritic cells; immunotherapy; inflammatory disease; regulatory T cells; tolerogenicity
Year: 2021 PMID: 33922658 DOI: 10.3390/ijms22094430
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923